Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

167 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Completed

A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration

NCT03689972

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • North Central Neurology Associates, P.C. Cullman, Alabama, United States
  • Alabama Neurology Associates Homewood, Alabama, United States
  • UCI MIND Irvine, California, United States
  • UC San Diego Movement Disorder Center La Jolla, California, United States
View all 107 locations
View Trial Details
Completed

An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

NCT05663853

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • The Johns Hopkins University Baltimore, Maryland, United States
  • MedStar Health Chevy Chase, Maryland, United States
  • Corinne Goldsmith Dickinson Center for MS New York, United States
  • Mellen Center Cleveland, Ohio, United States
View Trial Details
Completed

A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis

NCT02545868

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • North Central Neurology Associates Cullman, Alabama, United States
  • Territory Neurology and Research Institute Tucson, Arizona, United States
  • Fullerton Neurology and Headache Center Fullerton, California, United States
  • Scripps Clinic La Jolla, California, United States
View all 22 locations
View Trial Details
Completed

Study on the Effectiveness of EGb 761® vs Placebo Used for Cognitive Impairment in Patients With Multiple Sclerosis

NCT00276341

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cognition Disorders, +9 more
Locations
  • Centre Hospitalier du Pays d'Aix Aix-en-Provence, France
  • Hôpital Nord - CHU d'Amiens Amiens, France
  • Hôpital J. Minjoz Besançon, France
  • CHU de Bordeaux Bordeaux, France
View all 30 locations
View Trial Details
Completed

A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMS

NCT04121221

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Mapi Pharma Research site 08 Birmingham, Alabama, United States
  • Mapi Pharma Research site 11 Cullman, Alabama, United States
  • Mapi Pharma Research site 15 Pasadena, California, United States
  • Mapi Pharma Research site 14 Denver, Colorado, United States
View all 112 locations
View Trial Details
Completed

Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden

NCT05029206

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Sahlgrenska University Hospital Gothenburg, Sweden
  • Linköping University Hospital Linköping, Sweden
  • Skåne University Hospital Lund, Sweden
  • Örebro University Hospital Örebro, Sweden
View Trial Details

Related conditions